1
2
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T15601 |
IT-901
|
Others | Others |
IT-901 是一种具有口服活性和有效性的 NF-κB 亚基 c-Rel 抑制剂,对 NF-κB 和 c-Rel 与 DNA 结合的 IC50 分别为 0.1 µM 和 3 μM。IT-901 是一种具有抗肿瘤活性的萘硫代巴比妥酸酯衍生物,可用于预防和治疗人类淋巴瘤和骨髓瘤。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-05099 |
GBA/glucocerebrosidase Protein, Human, Recombinant (His)
glucosidase, β, acid,GLUC,GCB,GBA1,glucosidase, bet... |
Human | HEK293 Cells |
Mutations in the GBA gene, encoding the lysosomal hydrolase glucocerebrosidase (GCase), are the most common known genetic risk factor for Parkinson's disease (PD) and dementia with Lewy bodies (DLB). ASAH1 (acid ceramidase 1) and GBA2 (glucocerebrosidase 2) enzymes that mediate glucosylsphingosine production and metabolism are attractive therapeutic targets for treating mutant GBA-associated PD. | |||
TMPY-01579 |
GBA3 Protein, Human, Recombinant (His)
glucosidase, beta, acid 3 (gene/pseudogene),GBA3,MGC126878,K... |
Human | Baculovirus Insect Cells |
Cytosolic beta-glucosidase, also known as Cytosolic beta-glucosidase-like protein 1, GBA3, CBG and CBGL1 is a cytoplasm protein which belongs to theglycosyl hydrolase 1 family and Klotho subfamily. GBA3 / CBGL1 is a glycosidase probably involved in the intestinal absorption and metabolism of dietary flavonoid glycosides. GBA3 / CBGL1 is present in small intestine (at protein level). GBA3 / CBGL1 is expressed in liver, small intestine, colon, spleen and kidney. GBA3 / CBGL1 is down-regulated in r... |